منابع مشابه
Sublingual immunotherapy in children: the recent experiences.
PURPOSE OF REVIEW Sublingual immunotherapy (SLIT) is indicated for the use in pediatric patients suffering from allergic rhinitis or allergic rhinoconjunctivitis caused by environmental allergens, such as ragweed pollen, grass pollen, and dust mite. This review focuses on recent and relevant studies associated with the use of SLIT for these allergens in children by examining efficacy, safety, a...
متن کاملRecent advances in cancer immunotherapy
Laboratory and clinical investigations of immunotherapy in cancer treatment have been underway for the past several decades by attempting to stimulate, enhance, and modulate the immune system to detect and destroy cancer cells. Although immunotherapy has shown success in a wide variety of cancers previously: BCG in superficial bladder cancer, interferon-alpha in melanoma, and high-dose interleu...
متن کاملRecent Advances in Immunotherapy of Lung Cancer
Immunotherapy was long considered as an attractive modality in the treatment of lung cancer. However, clinical successes were hampered by the inability to achieve potent activation of the antitumor immune system and effectively overcome the immune suppressive environment associated with lung cancer. Recent advances in cancer immunotherapy demonstrate that these limitations can be surmounted. In...
متن کاملRecent advances in exosome-based cancer immunotherapy
The increasing understanding of exosome biology has sparked interest in their activities in the immune system. Exosomes are cell-derived extracellular vesicles at the nanoscale range, which have been thought to play important roles in intercellular communication and substance delivery. Recent evidence shows that exosomes are involved in the regulation of immune responses and anti-cancer immunit...
متن کاملRecent Advances in Immunotherapy in Metastatic NSCLC
Non-small cell lung cancer (NSCLC) is one of most common malignancies and the leading cause of cancer deaths worldwide. Despite advances in targeted therapies, majority of NSCLC patients do not have targetable genomic alterations. Nevertheless, recent discovery that NSCLC is an immunogenic tumor type, and several breakthroughs in immunotherapies have led to rapid expansion of this new treatment...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Allergology International
سال: 2013
ISSN: 1323-8930
DOI: 10.2332/allergolint.13-rai-0627